Loading chat...
IN SB0412
Bill
AI Summary
-
Requires accident and sickness insurance policies issued on individual or group basis to cover treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, including intravenous immunoglobulin therapy.
-
Mandates health maintenance organization contracts to provide the same coverage for these pediatric neuropsychiatric conditions with intravenous immunoglobulin therapy.
-
Prohibits insurance policies and HMO contracts from applying dollar limits, coinsurance, copayments, or deductibles to these treatments that are less favorable than those applied to coverage for physical illness generally.
-
Applies to all policies and contracts issued, delivered, amended, or renewed after June 30, 2018.
-
Expires July 1, 2021, with the effective date of July 1, 2018.
Legislative Description
Coverage for pediatric neuropsychiatric disorders. Requires a policy of accident and sickness insurance and a health maintenance organization contract to provide coverage for treatment of certain pediatric neuropsychiatric illnesses.
Last Action
First reading: referred to Committee on Insurance and Financial Institutions
1/8/2018